Clinical trial
IOP and Tolerability Study of Preserved Bimatoprost 0.1% or Tafluprost Unit Dose Preservative Free 15microgram/ml, in Patients With OHT or Glaucoma Suitable for Prostaglandin Therapy
NCT02471105 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- IOP and Tolerability Study of Preserved Bimatoprost 0.1% or Tafluprost Unit Dose Preservative Free 15microgram/ml, in Patients With OHT or Glaucoma Suitable for Prostaglandin Therapy
- Lead sponsor
- Universitaire Ziekenhuizen KU Leuven
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 30, 2015
- Completion date
- December 31, 2017
- Enrollment
- 67 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.